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Traditional medicine has been known by mankind since ancient times as a healthcare 
system. All cultures have used herbs throughout history and it was an integral part of 
the development of modern civilization. Primitive man observed and appreciated the 
great diversity of plants available to him. Plants provided food, clothes, shelter and 
medicine and still play a vital role in rural villages of South Africa. The medicinal uses of 
plants and animals have been developed through trial and error. Herbal plants produce 
and contain a wide variety of chemical substances that act upon the body’s immune 
system.   
The medicinal properties of Ipomoea oblongata (E.Mey.ex Choisy) in  this study was to 
determine the phytochemical content, antioxidant, anti-cancer and anti-diabetic 
properties of I. oblongata (Mothokho), a medicinal plant used by traditional medical 
practitioners of Thaba-Nchu in the Free State. The study was carried out in order to 
validate the ethnomedicinal claims made by the traditional medical practitioners and to 
evaluate the plant’s potential as a novel therapeutic agent.  
Twelve traditional medical practitioners of the Kopanang Dingaka Association were 
interviewed on the knowledge and use of I. oblongata (Mothokho). The phytochemical 
constituents of the plant were determined using standard screening methods. Testing 
for antioxidant properties (free radical scavenging activity) was carried out by means of 
the 2, 2- diphenylpicrylhydrazyl (DPPH) assays. The Sulforhodamine B assay was used 
to screen for anti-cancer activity in breast (MCF7), colon (HCT116) and prostate (PC3) 
cancer cell lines. Glucose uptake in C2C12 muscle cells was used to evaluate the anti-
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diabetic potential of I. oblongata. Methanol extract was fractionated using Ultra-Pure 
Liquid Chromatography (UPLC) to identify active compounds. 
The traditional medical practitioners cited the plant roots as the main ingredient in the 
treatment of respiratory infections, sexually transmitted infections, postnatal womb 
treatments, inflammation, arthritis, wounds and cancer. The methanol extract of I. 
oblongata showed remarkable (99.03%, 98.39, 71.31%) antioxidant potential in all 
triplicates tested which explains its use in oxidative stress-related diseases such as 
arthritis and cancer. Phytochemical tests showed the presence of carbohydrates, 
glycosides, steroids, terpenoids, alkaloids, flavonoids and tannins. However, the 
extracts were inactive against the cancer cell lines used. Glucose uptake by the C2C12 
muscle cells was increased by over 150% and was comparable to that of insulin and 
metformin, suggesting good anti-diabetic activity. Predicted compounds found were 
dihydroquercetin pentaacetate, actinorhodin and actinorhodine, using Chemspider 
analysis. These are possible compounds that could be found in the Ipomoea oblongata 
extracts when using nuclear magnetic resonance (NMR) to determine the structure and 
names of the active compounds. 
Ethnobotanical uses of Ipomoea oblongata were found to have a link with other 
ethnobotanical studies to capture the indigenous knowledge, culture and therapeutic 
uses. The phytochemical results of Ipomoea oblongata can contribute to the knowledge 
of new drug development as indicated by literature (Harbone; 1973, Soforowa, 1993; De 
et al., 2010) that plants contain phytochemical contents and phenolic compounds that 
are valuable as medicinal properties. Methanolic extract of Ipomoea oblongata 
presented high levels of antioxidant activity respectively, which can become a potential 
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antimicrobial agent and remedy oxidative stress related diseases. The anticancer 
properties were inactive and the cytotoxicity levels were found to below in I. oblongata. 
Low levels of cytotoxicity allow medicinal plants to be consumed by humans with fewer 
side effects however doses must be standardized. High levels of glucose uptake in 
muscle cells were indicated from the aqueous extract of Ipomoea oblongata, therefore 
showing great potential as an antidiabetic agent. Many medicinal plants have been 
validated as antidiabetic therapeutic agents in South Africa and the world. New 
treatment of cancer, diabetes, bacterial and viral infections is required from natural 
products that are cost effective with minimal side effects that can be used in health care 
systems. 
There is a correlation between the medicinal properties found in I. oblongata and the 
ethnomedicinal uses cited by the traditional medical practitioners. The plant I. oblongata 
has six ethno-pharmaceutical uses. I. oblongata is a good source of anti-diabetic and 
antioxidant agents that can be developed further. However the plant is not a good 
source of anticancer properties. Future research will be into the isolation and 
identification of the active compounds. 
© Central University of Technology, Free State
v 
ACKNOWLEDGEMENTS 
I would like to acknowledge the Research and Innovation fund, Central University of 
Technology and Medical Research Council South Africa for the full-time master’s 
program sponsorships. I would also like to acknowledge my supervisor, Prof. SS 
Mashele, and Dr IT Manduna for their guidance. I thank my fellow students (Refilwe 
Mhaladi, Damianfranklin Okolie, Pakiso Makhoahle, Euginiah Moleleki and Alice 
Maseloane) for their support and teamwork. I am grateful to the Kopanang Dingaka 
Association in Thaba-Nchu, Free State, especially Mrs Malebogang Letsoko, Ntjane 
Thabiso (Maele) and Mofamere Nomalinge (Mampheko), for sharing their knowledge of 
traditional medicines. Dr Elmarie van de Watt of the Department of Soil, Crop and 
Climate Sciences, University of the Free State, is acknowledged for allowing us 
(phytomedicine group) to use their facilities. 
© Central University of Technology, Free State
vi 
DEDICATION 
This work is dedicated to the Father Almighty (man upstairs), my two children, Kabelo 
and Kagiso, and husband, Phegelelo, for their support and understanding through this, 
the most difficult journey of my entire career.  I could not have completed this course if it 
had not been for their love and constant reminders of the bigger picture. 
 “Oh that You bless me indeed, and enlarge my territory, and let Your hand be with me 
and that You keep me away from evil.” 
1 Chronicles 4:9-10 
Thank you. 
© Central University of Technology, Free State
vii 






4. Level of schooling
Use 
5. Do you know this plant?
6. What are its names?
7. Do you use it?
8. What do you use it for?
a. If also used for animals, which animals?
b. Preparation for animal treatment
c. Animal diseases it cures
9. Which part is used for medicine?
Preparation 
1. How do you diagnose the disease? How do you know when to give this
medicine? 
2. How is it prepared?
3. Is the preparation the same for treating different diseases?
4. How is it taken by patients (e.g. orally) to treat different diseases?
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5. Is it used fresh or dry?
6. Do you mix it or combine it with other things to work properly?
7. Dosages?
8. Is it used concentrated or diluted?
9. Does it have any side effects?
10. What are the side effects?
11. What causes the side effects?
12. Can it be prescribed to everyone?
a. Recommended age for using the plant?
b. Gender of patients
Finding and storing it 
13. Are there any rituals that need to be observed when collecting/harvesting or
giving the medicine? 
14. Where do you find it?
15. When is it found (season)?
16. How is it harvested?
17. How are the harvested tubers stored?
18. How long can they be stored?
Propagation 
19. Is finding it a problem?
20. Is it found in the wild only or are there any muthi gardens?
21. Do you cultivate it or would you like to cultivate it?
22. How is it propagated?
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23. Is it easy or difficult to propagate? 
24. How long does it take to germinate?  
25. When does it germinate? 
26. Which part is used to propagate the plant (seeds, vegetative)? 
27. Conditions required for the plant to germinate  and grow 
28. What is production like (any diseases or temperature that lower the yield)?  
29. Are there other plants that you can use in place of it or instead of it.  
Trade 
30. Do you sell the plant? 
31. Where do you sell the plant? 
32. How much do you collect for sale per day/week/month/year? 
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Appendix B: Abbreviations 
 
1. µg: Microgram 
2. µl: Mmicro litres 
3. AP-1: Activator Protein-1 
4. CSIR: Centre for Scientific and Industrial Research 
5. CUT: Central University of Technology 
6. DMSO: Dimethyl Sulfoxide 
7. DNA: Deoxyribonucleic Acid 
8. DPPH: 2,2-Diphenyl-1-picrylhydrazyl  
9. DTP: Development Therapeutic Program 
10. g: Grams 
11. H2SO4: Sulfuric Acid 
12. IDDM: Insulin Dependent Diabetes Mellitus 
13. LC100: 100% Lethal Concentration 
14. LC50: 50% Lethal Concentration  
15. LCMS: Liquid chromatography Mass-Spectrometry  
16. mg: Milligrams 
17. ml: Millilitres 
18. mM: milli-Molar 
19. MRC: Medical Research Council 
20. MRDM: Malnutrition-r Related Diabetes Mellitus 
21. MTT: Mossman Tetrazole Test (3-(4,5-Dimethylthiazol-2-yl)-2,5-
Diphenyltetrazolium Bromide) 
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22. NAOH: Sodium Hydroxide 
23. NCI: National Cancer Institute 
24. NF-K: Nuclear Factor-Kappa 
25. NIDDM: Non-iInsulin Dependent Diabetes Mellitus 
26. nm: nanometers 
27. NMR: Nuclear Magnetic Resonance 
28. O2: Oxygen 
29. OH: Hydroxide 
30. ROO: Peroxyl radical 
31. ROS: Reactive Oxygen Species 
32. SBR: Sulforhodamine B  
33. SU: Sulphonylreas 
34. T0: Drug Addition 
35. TCA: Trichloroacetic Acid 
36. TGI: Total Growth Inhibition 
37. TZD: Thiazolidinedione 
38. UK: United Kingdom 
39. UN: United Nations 
40. UPLC: Ultra-pure Liquid Chromatography 
41. USA: United States of America 
42. WHO: World Health Organization 
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General Introduction and Literature Review 
  




Alternative therapies are treatments that should solve problems in a way similar to 
conventional treatment methods. These therapies include compounds that are isolated 
and extracted from natural sources such as medicinal plants. Many cancer drugs 
originate from plants, soil and marine microorganisms and fungi (Koduru et al., 2007). 
Compounds that are derived from plants have contributed significantly in the 
development of some useful anti-cancer drugs such as taxol, etoposide, vinblastine and 
vincristine. Current cancer treatment poses numerous problems such as adverse side 
effects, drug resistance and toxicity to non-cancerous cells. Drug resistance and toxicity 
are not unique to cancer therapy but are widespread. This has led to the search for new 
antimicrobial, anticancer, antidiabetic and many more therapeutic agents from other 
sources like plants with minimal side effects (Hong-Fang et al., 2009). 
Plants are natural sources that might have minimal or no side effects (Light et al., 2005). 
Medicinal plants in Southern Africa have been the point of interest for new drug 
development and the isolation of active compounds. Interest in this field has grown 
drastically in the last 10 years (Light et al., 2005). Medicinal plants can be seen as the 
way forward in future in terms of research and development on new therapeutic drugs 
(Makunga et al., 2008). According to Van Wyk (2011), more than 90 of the best known 
indigenous plants have shown commercial potential in a variety of applications as drug 
agents in South Africa. Traditional Medical practitioners, herbalists and rural dwellers 
have indigenous knowledge on using medicinal plants for treating ailments, but require 
support from researchers for scientific knowledge and validation of their work to be 
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recognized. These partnerships will lead to more plants being commercialized and 
documented to benefit all parties involved, including communities. 
The South African population relies more on traditional herbal medicines for treatment 
than on Western medicines. This forms an important base of the primary healthcare 
system in the country, which is rich in biodiversity, cultural diversity and traditional 
knowledge (Nair et al., 2011; Street et al., 2008).  According to Nair  et al., (2011) and 
van Vuuren (2008),  the Southern African region has a floral diversity of 30 000 species, 
which represents 10% of the world’s flowering plant population. Indigenous plants have 
been trusted by traditional medical practitioners for the treatment of diseases such as 
respiratory infections, reproductive health, problems with pregnancy, cancer, diabetes, 
etc. (Louw et al., 2002). 
1.2. Literature review 
1.3 Cancer 
Cancer is a malignant neoplasm (tumor), which involves unregulated cell growth that 
results in the formation of malignant tumors. The cancer cells are able to invade other 
parts of the body and may also spread to more distant parts of the body through the 
lymphatic system or bloodstream (Weinberg, 2007). 
 
1.3.1. Factors increasing the risk of cancer 
Tobacco use or tobacco smoke is a toxic mix of over 7 000 chemicals, which causes 
cancer of the mouth, nose, throat, kidney etc. (US Department of Health and Human 
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services, 2008). Continuous smoking damages deoxyribonucleic acid (DNA), tissue and 
cell structure and interferes with normal body processes (US Department of Health and 
Human Services, 2008). The transition from normal, healthy cells to cancer cells is a 
step-wise progression that requires genetic change in several different tumor 
suppressions. In order to generate a cancer cell, a series of mutations must occur in the 
same cell. Therefore, cancer is much more prevalent in elderly individuals (Hanna et al., 
2008). Cells in an elderly (70-year-old) person’s body have had more time to 
accumulate the requisite genetic changes needed to develop cancer, unlike those in a 
child (Hanna et al., 2008). Poor diets and obesity during the past several decades have 
enlarged the percentage of overweight and obese people. Obesity is associated with an 
increased risk of developing cancer of the esophagus, pancreas, colon and rectum, 
breast (after menopause), endometrium, kidney, thyroid and gall bladder (National 
Cancer Institute (NCI) Surveillance, 2007). 
Epidemiological studies of environmental pollutants over the last 40 years have shown 
that ambient air pollution caused by the incomplete combustion of fossil fuels is 
associated with relatively small particles that increase the rate of lung cancer. The small 
particles from fossil fuel combustion are the most dangerous, being deeply inhaled into 
the lungs and resulting in acute changes in lung function and respiratory infection. 
These particles settle in the areas where the body’s immune clearance mechanisms 
cannot eliminate them and become cancerous. Particulate matter is the source of the 
life- shortening effect of dry air, because polluted air contains small and large particles 
with chemicals. Chemicals found in the small particles tend to be active and become 
acidic, resulting in damage to lung cells (Cohen and Pope, 1995). Therefore an active 
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compound from plants is needed to assist in clearing inflammation of the lungs. The 
medicinal properties of I. oblongata will be investigated in vitro (artificial environment) 
for anti-cancer therapy to find a possible active compound(s) that could assist in 
eliminating chemicals causing cancerous cells. 
1.3.2. Cancer treatment 
The predictable methods of cancer treatment are radiation, surgery, chemotherapy, 
palliative care and some medicinal drugs (National Cancer Institute, 2010). Most of 
these treatments depend on the type of location and grade of cancer, as well as the 
person’s health and wellness. For instance, surgery has good outcomes for some 
cancers (i.e. skin, breast, etc.), whereas radiation is normally applied in conjunction with 
surgery or chemotherapy. An overview of the common side effects of conventional 
treatments is listed in Table 1.1. It is rare for any treatment to be used independently to 
combat the illness on its own (National Cancer Institute, 2010). 
 




1.Radiation therapy Skin rashes (such as redness/rash), loss of appetite and 
decreased number of white blood cells. 
2. Chemotherapy Loss of appetite, nausea, vomiting, hair loss and mouth 
sores. 
3.Hormonal Nausea, vomiting, weight gain, interrupted menstrual 
© Central University of Technology, Free State
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therapy periods and vaginal dryness. 
4.Surgery Lymphedema (post-surgery), tingling or numbness. 
General side 
effects 
Constipation, sleep disorders, delirium, loss of fertility 
(from some anti-cancer drugs) and fatigue. 
Source: National Cancer Institute, 2010 
1.3.3. Cancer and inflammation 
“Inflammation is a part of the host response to either internal or external environmental 
stimuli” (Aggarwal et al., 2006). It has been described as a localized protective reaction 
of tissue to irritation, injury, or infection, characterized by pain, redness and swelling. 
Many studies have indicated that patients with chronic inflammatory diseases have a 
bigger risk of developing cancer, diabetes, etc. Chronic inflammation is the most 
common type of inflammation linked with cancer. Key factors associated with chronic 
inflammation are the roles played by pro-inflammatory cytokines, chemokines, adhesion 
molecules and inflammatory enzymes (Aggarwal et al., 2006). 
In a study by Bucala and Seamas (2007), macrophage migration inhibitory factor (MIF) 
was determined to have unique biological activities. The regulation of tumor-
suppression genes, angiogenesis and cell senescence postulates MIF as playing an 
important role in linking chronic inflammation and cancer invasion. Long-term CD44 
activation plays a vital role in malignancy by activating breast cancer cell invasion. In 
order to maintain the development of tumor cells, there is interaction between tumor 
cells and the host’s microenvironment (Bucala and Seamas, 2007). The use of I. 
© Central University of Technology, Free State
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oblongata as treatment might aid in preventing the development of the tumor cells if 
antioxidants and anti-inflammatory activities are found in the plant. 
1.3.4. Cancer and antioxidants 
Atawodi, (2005) describes reactive oxygen species (ROS) or free radicals as a major 
cause of cellular damage. By using natural anti-oxidant compounds found in foods and 
medicinal plants, ROS can be scavenged for chemoprevention (Atawodi, 2005). Free 
radicals are generated as part of the body’s normal metabolic processes. ROS can 
result in DNA damage that may alter signal transduction (transfer of genetic material) 
forces, including induction changes in transcription factors (i.e. NF-K and AP-1), which 
are intermediate cellular stress responses such as diabetes, cancer, aging and other 
degenerative diseases (Olayinka and Okoh, 2010; Nibha and Manjula, 2008).  The 
increased level of radical activity (Atawodi, 2005), damage to the immune system and 
nervous system can be a result of chemical mobilization of fat stores under various 
conditions such as lactation, exercise, fever infections and even fasting (Atawodi, 2005). 
In cancer ROS are responsible for initiating the multistage carcinogenesis process, 
starting with DNA damage and accumulation of genetic events in one or a few cell lines. 
These cell lines lead to progressively dysplastic cellular appearance, deregulated cell 
growth and finally carcinoma. Therefore using free radical scavengers (antioxidants) 
has the potential to prevent and delay many of the known disorders (Atawodi, 2005). 
1.4. Diabetes 
The global prevalence of diabetes for 2000 and 2030 projections were conducted by 
age and sex from World Health Organization (WHO). The WHO state members and 
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United Nations (UN) population diabetes statistics was piloted for both rural and urban 
countries (Wild et al., 2004). The estimates for 2000 were 171 million people with 
diabetes at 2.8% and it was predicted that 366 million people would have diabetes by 
2030 at 4.4% (Wild et al., 2004; WHO statistics).  Leading countries in terms of the 
number of people with diabetes are India, China and the United States of America 
(USA); these are resourceful countries that can help develop technology for novel drugs 
from medicinal plants, which are natural sources. Factors contributing to the number of 
people with diabetes include population growth, aging, urbanization and others (Wild et 
al., 2004). In figure 1.1., the estimates of diabetes prevalence are shown in developed, 
developing countries and the world according to age. The age group of 64-65+ will have 
diabetes in the 2030 for the world and the developing countries.  These prevalence 
plays as an indicator that age is a contributing factor in diabetes. The prevalence of 
diabetes is higher in men than in women, but more women are diagnosed with diabetes. 
There are more women who test for diabetes and are much more health conscious than 
men. Therefore there is a need to develop an anti-diabetic drug from natural sources to 
enable most people to benefit from low-cost medication (Wild et al., 2004). 




Figure 1. 1 Estimates of diabetes prevalence in developed and, developing 
countries and the world according to age (Source: Wild et al., 2004 
© Central University of Technology, Free State
10 
 
The ethnobotany studies conducted on anti-diabetic activity show that about 800 plant 
species, such as Momordica charantia, Pterocarpus marsupium and Trigonella foenum 
greacum, have been reported to be potent for Type 2 diabetes (Patel et al., 2012a). 
Perez et al. (1998) indicated that plants demonstrating hypoglycemic effects have been 
used since ancient times to treat Type 2 diabetes. They also indicated the positive anti-
diabetic effects caused by compounds isolated from medicinal plants. This justifies 
plants such as I. oblongata being tested for new leads as diabetes drugs. The plants 
cited most often as being used as anti-diabetic treatments belong to the following 
families: Asteraceae, Fabaceae, Euphorbiaceae, Lamiaceae, Liliaceae and Poaceae 
(Marles and Farnsworth 1995). The Eastern Cape Province used plants from the 
following families; Asteraceae, Hypoxidaceae, Asphodelaceae, Apocynaceae, Apiaceae 
and Buddlejaceae to treat diabetes. The plants parts commonly used were leaves, 
twigs, roots and corms as infusions taken orally as shown in Table 1.2. Mostly the 
infusions from fresh leaves were boiled or soaked in water and roots and corms were 
also boiled (Erasto et al., 2005). Medicinal plants have shown potential in treatment of 
diabetes in literature and the people utilizing plants. Asteraceae family indicates to be 
commonly used with antidiabetic activity. 
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Table 1.2 Plants used for the treatment of diabetes in the Eastern Cape Province, 
South Africa 
Family & scientific name Local name Parts used Preparation of medicine 
Asteraceae Herichrysum 
odoratissimum L 
Imphepho Whole plant The fresh plant is crushed and 
boiled and the infusion is taken 
orally. 
Herichrysum nudifolium L. Ichocholo Leaves, roots Fresh leaves or roots are boiled,  
then taken orally. 
Herichrysum petiolare H & 
B.L. 
Imphepho Whole plant A fresh plant is crushed, boiled 
and the concentrated solution is 
taken orally. 
Artemisia afra Jacq. Umhlonyane Leaves, roots Leaves or roots are boiled, then 
the infusion is mixed with sugar 
to mask the bitterness. 
Vernonia oligocephala Sch. 
Bip. 
Umhlunguhlungu Leaves, twigs, roots Fresh leaves, roots or twigs are 
pulverized, and the infusion is 
taken orally. 
Vernonia amygdalina Del. Umhlunguhlungu Leaves Pulverized fresh leaves are 
soaked in water and the solution 
is taken orally. 
Brachylaena discolor DC. UmPhahla Leaves Leaves are boiled and the 
infusion is taken orally 
Hypoxidaceae Hypoxis 
hemerocallidea Fisch. & C. 
A 
Inongwe Corms Fresh corms are crushed, boiled 
and taken orally 
Hypoxis colchicifolia Bak. 
Asphodelaceae 
Inongwe Corms Fresh corms are crushed, boiled 
and taken orally 
Bulbine natalensis 
(Syn. B. latifolia) Mill. 
Ibhucu Roots Fresh roots are boiled and the 
infusion is taken orally. 
Bulbine frutescens L. Ibhucu Roots An infusion is made from fresh 
boiled roots and is taken orally. 
Apocynaceae Catharanthus 
roseus 
Isisushlungu Leaves An infusion is made from boiled 
leaves and taken orally. 
Apiaceae Heteromorphica 
arborescens. Hochst. 
Ex A. Rich. 
Umbangandlala Leaves and roots An infusion is made from boiled 




Umgeba Leaves and twigs An infusion is made from leaves 
or twigs and taken orally. 
Source: Erasto et al. (2005) 
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1.5. Ipomoea oblongata (E. Mey. ex Choisy) 
I. oblongata (E. Mey. ex Choisy) with the synonym Turbina oblongata (A. Meeus) is a 
member of the Convolvulaceae family. Common vernacular names are wild morning 
glory (English), purperwinde (Afrikaans), Ubhoqo (Zulu), Mothokho (Sesotho) (Sobiecki 
2008; Roux 2006). A image of I. oblongata is shown in Table 1.3. Ipomoea oblongata is 
widely distributed over Southern African countries such as Botswana, Malawi, South 
Africa (mainly in the Free State and KwaZulu-Natal), Swaziland, Zimbabwe and 
Tanzania (Sobiecki 2008; Roux 2006). The collection of Ipomoea oblongata was done 
at Selosesha location next to Serwalo in Thaba-Nchu, Free State. Figure 1.2. A shows 
Ipomoea oblongata taken in another province in Free State and figure 1.2.B shows the 
tuber of Ipomoea oblongata in a cross sectional view. This is how the traditional medical 
practitioners harvest the plant. The Ipomoea oblongata plant with its seeds taken in 
Thaba-Nchu is shown in figure 1.3.A and B. During harvest system the traditional 
medical practitioners are able to identify the plant as shown in the figures 1.2 A and B 
and figure 1.3 A and B. In literature there has not been any scientific work reported yet 
with the use of Ipomoea oblongata. This study is the first report to be presented with the 
medicinal properties of Ipomoea oblongata from Convolvulaceae family thus far. 
 






Figure 1. 2 A: Ipomoea plant,   B: Tuber of I.oblongata; 
photograph taken at Bothaville 
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Table 1.3 Description of Ipomoea oblongata 
Part Description Size Shape 
Tuber Perennial large fusiform tuberous 
root 
1 m long  
Stems Annual, prostrate, petioles, leaves, 
penducles and calyx form a zigzag 
pattern; pubescent with 
yellow/brownish hairs 
2 m long Angular 
Leaves Vary in size and shape, either 
oblong or elliptic 
20-150 x 4-8 
mm 
Ovate/ Linear 
Base   Subcordate to rounded 
Apex Upper surface is yellowish strigose 
and lower surface is thin/more 
dense 
 Acute to emarginate, 
margin ciliate 
Petiole Shorter than leaves   
Penducles One is severally flowered and 
shorter than leaves 
  
Bracteoles Hairy, shorter than sepals  Lanceolate 
Pedicles  ≥ 6mm  
Sepals Sub-equal, outer ones are hairy 
and inner ones are less hairy 
12-25 mm 
long 
Lanceolate to ovate, 
acute or acumianate 
Corolla Wide, magenta, mid-petaline areas 




Capsule Style base persistent, glabrous, 






Seed 1-4 seeds, punctate to smooth and 
grey. Flower in October- April and  
mostly in December-January 
+7 mm long Glabrous 
Source: Roux  (2006). 
A 
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1.6. Purpose of the research 
Traditional Medical Practitioners use Ipomoea oblongata for a variety of ailments. The 
aim of this study was to evaluate some medicinal properties of Ipomoea oblongata.  
1.7. Objectives 
In order to achieve the aim stated above, the study will focus on the following 
objectives: 
• To document the medicinal use of Ipomoea oblongata in Thaba-Nchu, Free 
State. 
• To determine the phytochemical contents of Ipomoea oblongata extracts and   
antioxidant properties.  
• To evaluate the effects of the extracts in cancer cell lines in vitro. 
• To determine the anti-diabetic properties of the plant extracts. 
• To assess the cytotoxicity of extracts from I. oblongata on chang and muscle 
cells. 
1.8. Overview of the dissertation 
This study is presented in five sections (Chapters 2-6). Chapter 2 reports on he, 
Ethnobotanical uses of Ipomoea oblongata (Mothokgo). The plant part used and the 
preparation is documented. Chapter 3 discusses the phytochemical contents of the 
extracts. The standard screening methods were used to determine the contents from 
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methanol, water and dichloromethane. The next chapter (4) evaluates the antioxidant 
activity of Ipomoea oblongata using the free stable radical, 2, 2- diphenylpicrylhydrazyl 
(DPPH) method.  Antioxidant activities played an important role in determining the other 
medicinal uses of I.oblongata. Chapter 5 discusses anti-cancer activity in medicinal 
plants and the cell lines used for this assay. The last chapter evaluates the effects of 
medicinal plants in treating diabetes and the cytotoxicity effects of I. oblongata as an 
anti-diabetic agent. 
The plant material and extraction methods used in this study are the same for all 
experiments performed to determine the medicinal properties of I. oblongata. 














Figure 1. 4 Methodology summary 
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 2.1. Introduction  
Ethnobotany studies are common ways that are carried out by researchers to 
understand the use of traditional herbal medicines by traditional doctors, herbalists, 
rural dwellers and communities at large. This contributes to scientific literature, 
medicinal usage, conservation and biodiversity of plants and the knowledge of 
traditional medical practitioners. An ethnobotany study was conducted by Erasto et al. 
(2005) in the Eastern Cape to determine the use of medicinal plants to treat diabetes. 
The results of the survey showed that it is common practice to treat the ailment with 
traditional herbal medicines.  Four plants (Herichrysum odoratissimum, Herichrysum 
petiolare, Hypoxis hemerocallidea and Hypoxis colchicifolia) are frequently used to treat 
both humans and livestock (Erasto et al., 2005).  
 
The families Asteraceae, Hypoxidaceae, Asphodelaceae, Apocynaceae, Apiaceae and 
Buddlejaceae have proven to be the most effective treatment for diabetes in the Eastern 
Cape (Erasto et al., 2005).  This validates the use of surveys and questionnaires among 
traditional medical practitioners as effective ways to determine how they use medicinal 
plants, which can play a partial role of novel drug discoveries. Researchers will 
investigate the claims on healing properties using appropriate scientific models in the 
laboratory to yield new active compounds that can lead into new therapeutic agents. 
2.2. Aim of ethnobotany survey 
The aim of this study was to determine the ethnobotanical uses of I. oblongata 
(Mothokgo) by traditional medical practitioners. 




An interview guide about I. oblongata (Mothokho) that was prepared for the traditional 
medical practitioners of Kopanang Dingaka Association as shown in figure 2.2., from a 
small village called Serwalo (Koppie) in Thaba-Nchu, Free State Province, South Africa.  
Serwalo is located in Thaba-nchu, Free State, South Africa, with the following 
geographical coordinates: 29° 12' 0" South, 26° 47' 0" East.  Each interview was 
conducted privately to eliminate repetition of what another candidate would mention 
refer to figure 2.2., as it is believed that each traditional healer uses medicinal plants 
differently, including I. oblongata. 
Interview questionnaires were drafted and modified according to what the researcher 
wanted to understand about the traditional knowledge and uses of the plant by the 
traditional medical practitioners. The questionnaire was divided into six sub-headings: 
Interviewee’s details, use, preparation, finding and storage, propagation and trade. 
The following equation was used to determine the importance of the plant used: 
UIV = ƩSs 
Ss=F ̷ (NmP) salience scores (Hoffman & Gallaher, 2007) 
F= Frequency 
mP= the mean position in which the species is mentioned 




Figure 2. 1 Interviews at Serwalo Thaba-Nchu 
 
Figure 2. 2 Kopanang Dingaka Association 
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2.4. Results and Discussion 
The method of extraction used is boiling and mixing the plant with only water as a 
solvent. The traditional medical practitioners cited the plant roots as the main ingredient 
in the treatment of respiratory infections, STI’s, postnatal womb treatments, 
inflammation, arthritis, wounds and cancer. The Use Importance Value formula is used 
to calculate how significant the common uses of I. oblongata are to the traditional 
medical practitioners and what the specific disease are that can or are being treated. In 
ethnobotany salience scores are utilized in order to determine the use importance value 
found in surveys about the plant use and its healing properties. Others use importance 
values may include everything significantly related to the plants properties, plant parts 
used, etc (Hoffman & Gallaher, 2007). 
 The illnesses were grouped into respiratory infections, pregnancy and postnatal, 
antimicrobial infections, cardiovascular diseases, and inflammatory diseases for the 
salience scores to determine their use importance and the salience were less than 1 as 
tabulated in table 2.1. The roots of Ipomoea oblongata are the most important plant part 
used to treat respiratory infections, inflammatory diseases, diarrhoea, and nausea, as 
shown in table 2.1., with reference to salience scores. 
Other findings from the questionnaire showed that Ipomoea oblongata is found on 
mountains and river banks. The preferred method of storage is in bags, plastic jars with 
lids, newspapers and dry brown bags.  In propagation, the harvest seasons are January 
to March, October to December are good seasons where I. oblongata has seeds, and 
flowers. In April to September the I. oblongata is still visible but very dry, therefore those 
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months are not suitable for harvesting. Kopanang Dingaka association utilizes digging 
to harvest the tuber. The association does not trade Ipomoea oblongata because they 
are in possession of recognized licenses to harvest indigenous plants. 
 
Table 2.1. Uses of I. oblongata determined by salience scores 
Ailments Plant part used Salience scores 
Respiratory infections Roots 0.5714 
Inflammatory diseases Roots 0.5436 
Cardiovascular diseases Roots 0.02787 
Pregnancy and postnatal Roots 0.3077 
Diarrhoea and nausea Roots 0.5000 
Cancer Roots and leaves 0.0833 
Wounds Roots 0.3000 
STIs Roots and leaves 0.2308 
 
Preservation of the indigenous knowledge plays a vital role in the discipline of 
Ethnobotany science and conservation, (Kunwar and Bussmann, 2008). In this study 
twelve informants were interviewed with regard to indigenous use of Ipomoea oblongata 
(Mothokgo). The results of the surveys displayed ailments that are treated with Ipomoea 
oblongata. In this way plant-people relations are documented. The illnesses were 
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grouped into respiratory infections, pregnancy and postnatal complications, 
antimicrobial infections, cardiovascular diseases and inflammatory diseases for the 
salience scores to determine use, importance and salience. The salience score were 
found to be lower than 1, as presented in table 2.1. Salience score lower than 1, 
presented the use importance value in the medicinal properties claimed made by the 
informants. Data for Ethnobotanical surveys is collected through questionnaires and 
personal interviews to be explored for therapeutic uses of medicinal plant and 
safeguarding of indigenous knowledge concepts, (Mohammad¹ and Mohammed², 
2013).  After analyzing the survey and claims by traditional medical practitioners, the 
researcher valided some of the medicinal uses. The medicinal properties (anticancer, 
anti-inflammation, antidiabetic, and antioxidants) were major role players for validation. 
The plant was found to be the main ingredient (activity) that the traditional medical 
practitioners used to mix with other plant material to make concoctions. In a study 
conducted with the Taungya community, the outcomes reveled different application 
forms such as powder, juice, decoctions , infusions, poultice and oral administration of 
diverse medicinal plants, (Poonam and Singh, 2009). Some of the applications are the 
same as those that were indicated by the informants of Ipomoea oblongata. Table 2, is 
an indication of how the traditional medical practitioners are utilizing Ipomoea oblongata 
as the main source of treating different ailments. After analysing the survey and claims 
by traditional medical practitioners, we focused on cancer, diabetes and antioxidants (as 
the play major roles in healing and restoring above mentioned ailments). In a study 
conducted for the ethnobotanical uses of Sansevieria Thunb (Asparaceae), four 
parameters were identified (medicinal use, horticulture use, food administration and the 
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specific plant parts used) from interviewing the informants which were local 
communities (Nyenya  et al., 2014). Traditional botanical knowledge of medicinal plants 
is retained in populations that utilized medicinal plants for therapeutic uses, (Cornara et 
al., 2014). The indigenous knowledge of medicinal plants was obtained from local 
communities, rural dwellers, and herbalist for documentation of ethnobotanical uses.  
2.5. Conclusion 
Ipomoea oblongata has a wide variety of medicinal applications. The plant is the main 
ingredient that the traditional medical practitioners use to make their herbal 
preparations. The root of I. oblongata was found to be the plant used most often to treat 
different ailments in the Thaba-Nchu community in the Free State.  
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Phytochemical Composition of Ipomoea oblongata 
  




Plants produce bioactive compounds known as phytochemicals, which are natural and 
non-nutritive. Phytochemical constituents of plants act as protective (nutritional and 
medicinal) agents against external stresses or attacks in the human body (Chew et al., 
2011, Kolachi et al., 2010). The biosynthetic origin of phytochemicals allows them to be 
divided into the following categories; phenolics, alkaloids, steroids, terpenes, saponins 
and many more (Seeram et al., 2004). Phytochemicals found in medicinal plants 
influence bioactivity, such as anti-mutagenic, anti-carcinogenic, antioxidant, 
antimicrobial and anti-inflammatory agents. Bioactive compounds that are found in 
Ipomoea species are flavonoids, glycosides, proanthrocyanidins (condensed tannins) 
and anthocyanins (Seeram et al., 2004). Leaves, stems and tubers of other Ipomoea 
species have been validated for phytochemical compounds, antimicrobial, antibacterial 
and anti-inflammatory properties in literature. I. oblongata has not been scientifically 
validated yet for its activities and bioactive compounds. 
Tannins are stable antioxidants that inhibit cell protein synthesis, aid in wound healing 
and inhibit the growth of microorganisms to make microbial proteins; they are also used 
for treatment of diarrhea and dysentery. Saponins and glycosides are responsible for 
upper respiratory tract inflammation properties, anti-diabetic, antitumor activity and 
antifungal properties (Singh et al., 2011). Alkaloids have analgesic, anti-inflammatory 
and adaptogenic properties to alleviate pain and develop resistance against diseases 
and stress. The last important phytochemical compound is flavonoids, which have 
antioxidant activities.  All these compounds are naturally found in medicinal plants and 
play a significant role in primary health treatments. Natural phenolic compound 
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flavonoids form the largest part (group) and tannins form the most important group of 
the polymeric group of materials found in plants (Harbone, 1973). Phenolic compounds 
are also known for their wide range of plant substances, which are common in aromatic 
ring bearing. These bioactive compounds are water-soluble and they occur combined 
with glycosides to form the major group of phytochemical compounds (Harbone, 1973).  
Phenols are also known to be potent antioxidants and free radical scavengers because 
of their ability to act as hydrogen donors, metal chelators, singlet oxygen quenchers and 
reducing agents (Chew et al., 2011). 
Preliminary phytochemical screening is essential for testing different extracts that were 
extracted using different solvents. In this case methanol, aqueous, and dichloromethane 
solvents were used in plant extraction and were used for the detection of different 
compounds by qualitative testing methods (De et al., 2010). The aim of the study was to 
determine which phytochemicals are present in the root extract of I. oblongata, as this 
plant has not been studied thoroughly yet. 
3.2. Methods 
The procedure that was followed is described below and was used for all the 
experiments. 
3.2.1. Plant material 
I. oblongata was donated by one of the traditional medical practitioners of Kopanang 
Dingaka association. The plant was collected in Thaba-Nchu, identified by the traditional 
medical practitioners and a voucher specimen (KT001/2013) was kept at the Central 
University of Technology Free State and authenticated by scientists at the National 
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Botanical Gardens in Bloemfontein. Plant material (roots) were dried in the oven at 40⁰C 
for 5 days, crushed into a fine powder and stored in a plastic jar. The plant was kept in a 
cool dry area in the laboratory (Mashele and Kolesnikova, 2010). 
3.2.2. Preparation of extracts 
For the preparation of aqueous (H2O), methanol and dichloromethane extracts, 
Ipomoea oblongata roots were weighed to obtain 10 g. Plant roots were dried in the 
oven at 40⁰C for 5 days, crushed into a fine powder material.  The powdered material 
was soaked for 72 hours in 150 ml of the different solvents and stirred using a rotary 
shaker. The water, methanol and dichloromethane extracts were filtered through 
(Whatman No. 1) filter paper. The solvents were dried at 40⁰C using a rotary evaporator 
to remove the solvents and make the final volumes of the original plant material. 
3.2.3. Screening of Ipomoea oblongata 
The Ipomoea oblongata extracts were used to detect saponins, carbohydrates, proteins, 
flavonoids, tannins, steroids, terpenoids, glycosides and alkaloids qualitatively (De et 
al., 2010). All the chemical tests were carried out on the methanolic and water extracts 
using standard procedure to identify the chemical constituents by colour changes (De et 
al., 2010; Trease et al., 1989; Harbone, 1973; Sofowara, 1993). The dichloromethane 
was excluded in the screening because the water and methanol extract displayed the 
type of phytochemical constituents present in the plant. 
Test for saponins 
In this test 0.7 mg of the extract was dissolved in 3 ml of distilled water and shaken 
vigorously. The formation of foam was an expected outcome. 
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Test for carbohydrates 
The Benedict’s test was performed using 0.2 mg of the extract, which was dissolved in 2 
ml of methanol. The sample of 1 ml (1000 ul) and 1 ml of Benedict’s solution were put 
into a test tube. The expected color change is from green to bluish-green. 
Test for protein 
Biuret reagents were used to test for proteins. The test was carried out by measuring 0-
2 mg of the extract, re-dissolved in 2 ml of methanol. A few drops of 1% copper sulfate 
(CuSO4) and 4% sodium hydroxide (NaOH) was added to the extract. The expected 
result would be violet color change. 
Test for flavonoids 
To test for flavonoids 5 ml of dilute ammonia solution were added to  the methanol and 
distilled water extracts before adding a few drops of concentrated sulfuric acid (H2SO4). 
A yellow coloration observed would indicate the presence of flavonoids. 
Test for tannins 
The methanol and water extracts were each re-dissolved in 2 ml methanol and 2 ml 
distilled water (solvents of extraction), then 3 drops of 0.1% ferric chloride solution were 
added. The formation of blue-black or brownish green precipitation in the solution 
indicated the presence of tannins. 
Test for steroids and terpernoids (Salkowski test) 
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In this procedure 0.2 mg of extract was dissolved in 2 ml of solvents of extractions of 
methanol and distilled water, then the extracts were premixed with 1 ml of chloroform. 
Afterwards, concentrated sulfuric acid (H2SO4) was added to the sample. Formation of 
a layer would be visible. These experiments cause a reddish brown color precipitate at 
the border or interface of chloroform and H2SO4, to show the presence of steroids and 
terpenoids.  
Test for cardiac glycosides (Keller-Killani test) 
In this test 2 ml of methanol extracts and 2 ml of distilled water extracts were dissolved 
in the solvents of extraction. The extracts were both treated with 2 ml of glacial acetic 
acid and one drop of ferric chloride solution, before the addition of 1 ml concentrated 
sulfuric acid. A brown ring of the interface indicates the deoxysugar characteristic of 
cardenolides. A violet ring appears below the brown ring interface, while in the acetic 
acid layer, a greenish ring gradually forms throughout the thin layer. 
Test for alkaloids (Meyer’s test) 
To test for alkaloids, 1 g of the methanolic and water extracts was re-dissolved in 3 ml 
methanol and 3 ml distilled water; 1 ml Meyer’s solution (potassium mercuric iodide 
solution) was added to 200 ul of the samples. The expected color change was to cream 
and orange-brownish. 
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3.2.4. Determination of total phenolic content of extracts from 
Ipomoea oblongata 
The principle behind this study was to evaluate the amount of total polyphenols found in 
the methanol extract, water extract and dichloromethane extract of I. oblongata. The 
Gallic acid standard curve was obtained by weighing 0.250 mg and dissolving it in 0.1 
ml methanol to make a stock solution. The extracts in their solvents of extraction and 
Gallic acid were diluted to different concentrations (2.5 mg/ml and 5 mg/ml). Stock 
solutions were made from 0.010 mg of crude extracts (methanol, water and 
dichloromethane) and re-dissoved in 2 ml of each solvent of extraction. 
A 50 ml volumetric flask was used for the experiment. In the flask 46 ml of distilled water 
were added, and then 5 ml of ethanol, 1 ml of Folin-Ciocalteu (FC) reagent from 
(Sigma) was also added. After 3 minutes the mixture was topped up to 50 ml by adding 
2.9 ml of sodium bicarbonate and 0.01 mg of the Gallic acid (Waterhouse et al., 2003). 
This procedure was repeated for the methanol, water and dichloromethane extracts. 
The samples and the control were incubated in the dark for two hours. The absorbance 
was read at 760 nm using a spectrophotometer (Thermo Spectronic, Helious Epsilon 
model, USA) 
The total phenolic content can be expressed as milligram (mg) Gallic acid equivalents 
(GAE) per milligram of the dry material (Gulluce et al., 2007; Waterhouse, 2003). This 
method was repeated for each extract. 
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3.2.5. Identification of active compounds by LCMS/UPLC 
Ultra-pure Liquid Chromatography (UPLC) was conducted in order to establish which 
compounds were active in I. oblongata. The instrument used for UPLC was the Water 
Synapt G2 at a flow rate of 0.4 ml/min and 0.1% formic acid to acetonitrite gradient at 
Water UPLC BEN C18, 2.1 x 100 mm column. Electrospray negative was used as a 
source with capillary voltage 3 kV and cone voltage 15 V. This was done in 
collaboration with Stellenbosch University.  
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3.3. Results and Discussion 
The phytochemical composition and primary metabolites of the water, methanol and 
dichloromethane extracts are shown in Table 3.1. The negative sign indicates absence 
of chemical composition. The presence of the constituents is indicated with the plus sign 
in the table. Total phenolic content of Ipomoea oblongata is represented in table 3.2 as 
gallic acid equivalence milligrams per liter. The gallic acid linear graph (fig.3.1) was 
used as standard to determine the phenolic contents of the ipomoea extracts.  The 
active compounds that gives I. oblongata its medicinal properties is shown in table 3.3 
 Table 3.1. Phytochemical screening compound results 
 
Phytochemicals Tests Methanol extract Water extract 
Carbohydrates Benedict’s + + 
 Fehling’s + + 
Cardiac glycosides Keller-Killani test + + 
Saponins Sofowara - - 
Proteins Biuret’s test - - 
Steroids Salkowski test + + 
Triterpernoids Salkowski test + + 
Alkaloids Sofowara + + 
Flavonoids Sofowara + + 
Tannins Sofowara + + 








Table 3.2 Total phenolic compounds in GAE 
  Phenolic contents   
Extracts TPL (GAE) Concentrations % Content 
Methanol 0.041109333 2.5  1.644373  
Methanol 0.0801632 5  1.603264  
Dichloromethane 0.041109269 2.5  1.644371  
Dichloromethane 0.040595467 5  0.811909  
Water 0.0319882 2.5  1.279528  
Water 0.0608932 5  1.217864  
 
y = 0.1927x + 0.0026 


























Figure 3. 2 UPLC detection peaks of I. oblongata methanol extracts 
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The plant I. oblongata was tested to see if it could form a database for the presence of 
phytochemical compounds and phenolic contents in the Convolvulaceae family. The 
aim was to determine the presence of phytochemical contents and phenolics. I. 
oblongata was found to have listed secondary metabolites as shown in Table 3.1, but 
the tests for saponins and proteins were negative. Ipomoea species (Ipomoea batata L 
and Ipomoea carnea) are known through literature to contain flavonoids, tannins, 
saponins, steroids, phenolic compounds and alkaloids (Khatiwora et al., 2010). 
Flavonoids are the most extensively studied phenolics and antioxidant compounds 
compared to alkaloids, saponins and many more bioactive compounds, which also play 
significant roles in pharmacology (Khatiwora et al., 2010). There is a gap to determine 
the mechanisms by which other compounds can be beneficial to drug development. 
This shows that I. oblongata in this study has potential to be an antimicrobial agent 
because of the phenolics, flavonoids, glycosides and tannins that are present. This is 
the first time phytochemical compounds of I. oblongata have been studied or reported in 
literature. 
The methanolic extracts and dichloromethane extracts as particularized in results had 
similarities at 2.5 mg/ml concentrations with a GAE of 0.04 and 1.64 % phenolic content 
found in each 2.5 mg/ml. The water extract was a little lower at the same concentration 
of 2.5 mg/ml with GAE of 0.03 and contained about 1.28% phenolic content in the same 
concentration as shown in Table 2. Phenolic contents of I. oblongata are influenced by 
the presence of flavonoids in the plant. The total phenolic contents are considered to be 
low, as the experiment was conducted at very low concentrations. The Gallic acid, 
flavonoids and other plant phenolics are reported by Khatiwora et al. (2010), as a 
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natural inhibitor of flowering in leaves and stems and are also found in bark and woody 
plants, so the results of this study correlate with the literature on the plants.  Even at 
lower concentrations the phenolic compounds have substantial positive effects, such as 
antimicrobial, antioxidant, anti-inflammatory, antiviral, antimutagenic and chemo-
preventative properties (Naidoo et al., 2006; Okem et al., 2012).  Figure 3.1 shows the 
standard curve obtained for the Gallic acid. 
UPLC was able to detect peaks and indicate chemical formulas that could be active in 
the methanol extract (Table 3.3). This will lead to fractionation of the plant’s active 
compound/s and structure using Nuclear Magnetic Resonance (NMR) spectroscopy of 
this compound.   
3.4. Conclusion 
This is an indication that I. oblongata can play an important role in treating diseases 
caused by oxidative stress, which releases ROS and free radicals. There is a correlation 
between antioxidant abilities and total phenolic content that is highly positive and 
indicates the major contribution of phenolic plants. 
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Antioxidant Activity of Ipomoea oblongata 
  




Antioxidants are described as a vital health-protecting factor, which can reduce the risk 
of ailments such as cancer and cardiological diseases. Antioxidants can be found 
naturally in plants, whole grains, fruit and vegetables. There are various known 
antioxidant compounds that can reduce the risk of ailments, such as vitamin C and E, 
carotenes, phenolic acids and phytoestrogens (Prakash et al., 2001, Singh et al., 2011). 
The aim of antioxidant activity is to investigative its scavenging activity or potential 
against free radicals such as 2, 2- diphenylpicrylhydrazyl (DPPH) radical, superoxide 
anion radical (O2), the hydroxyl radical and the peroxyl radical. 
It has been described that ROS or free radicals are a major cause of cellular damage, 
which occurs in biological systems as a result of different causes (Prakash et al., 2001; 
Seifried et al., 2006, Singh et al., 2011). By using natural anti-oxidant compounds found 
in foods and medicinal plants, ROS can be scavenged for chemoprevention (Atawodi et 
al., 2005. ROS can result in DNA damage that may alter signal transduction (transfer of 
genetic material) forces, including induction changes in transcription factors (i.e. NF-K 
and AP-1), which are intermediate cellular stress responses such as diabetes, cancer, 
aging and other degenerative diseases (Olayinka and Okoh, 2010; Nibha and Manjula, 
2008).  Metabolism of stress hormones results in simpler, rather slow free radical 
molecules (Atawodi et al., 2005; Middleton et al., 2000). 
 
 Defense mechanism provided by the antioxidant systems is essential to the survival of 
human immunity. The mechanism can function at different levels within the cells through 
the following actions: prevention of the radical formation, stopping formed radicals, 
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repairing oxidative damage, increasing the elimination of damaged molecules and 
recognition of excessively damaged molecules (Middleton et al., 2000; Singh et al., 
2011). 
 
These entire preventative mechanisms are not repaired but rather eradicated to prevent 
mutations from occurring during cell replication. The anti-oxidant shield involves both 
enzymatic mechanisms (which utilize specific enzymes such as superoxide dismutase, 
catalase and glutathione peroxidase), and non-enzymatic mechanisms, which utilize 
nutrients and minerals (Aggarwal and Shishodia, 2005; Middleton et al., 2000). The 
classification of non-enzymatic anti-oxidants is regarded as water-soluble or lipid-
soluble depending on their action, primarily in the aqueous phase or in the lipophilic 
region of the cell membranes (Middleton et al., 2000). Other non-enzymatic anti-
oxidants include antioxidant enzyme cofactors, oxidative enzyme inhibitors and 
transition metal chelators such as ethylene diamine tetra-acetic acid (Aggarwal and 
Shishodia, 2005; Middleton et al., 2000). There is a need to establish enzymatic or non-
enzymatic mechanisms that are found in anti-oxidants from Ipomoea oblongata. 
4.2. Methods 
The plant material and extraction method used in this experiment is described in 
chapter 3, section 3.1.1, plant material and section 3.2.2, preparation of extracts above. 
Principle 
Free radical scavengers function by donating an electron to the free radical therefore 
pairs with the unpaired electron and thus stabilizes it. 
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4.2.1   (DPPH) (2.2-diphenyl-hydroxyl) Assay 
The free radical scavenging activity screening was carried out using 0.004% of 2, 2- 
diphenylpicrylhydrazyl DPPH (Sigma) and Ascorbic acid as standard. DPPH solution 
without sample solution was used as negative control and ascorbic acid was used as a 
positive control. The blank used for both ascorbic acid and the sample was 1 ml of 
methanol. About 0.004 g of DPPH was weighed to make 1 mM and then added to 100 
ml of methanol in a flask. For ascorbic acid 0.001 mg of ascorbic acid powder was 
weighed. It was then diluted with 1 ml of distilled water in the 50 ml tubes before 2 ml of 
DPPH was added to the tubes for serial dilutions using. The concentrations that were 
obtained for ascorbic acid were 1 mg/ml; 0.5 mg/ml; 0.25 mg/ml; 0.125 mg/ml; 0.06 
mg/ml; 0.03 mg/ml and 0.015 mg/ml (Conforti et al., 2008; Brand-Williams et al., 1995). 
The ascorbic acid was incubated in the dark for an hour. The absorbance was read at 
517 nm using a (Thermo Spectronic, Helious Epsilon model, USA) spectrophotometer 
(Gulluce et al., 2007). The test was done in triplicate. 
The stock solution was 0.002 mg of the methanol root extract mixed into 1 ml of 
methanol solvent. The stock solution was made and dilutions were obtained using the 
same method as for the ascorbic acid. Afterwards 2 ml of the DPPH was added to the 
extract dilutions. The samples were incubated in the dark for an hour. The absorbance 
was read at 517 nm using a (Thermo Spectronic, Helious Epsilon model, USA) 
spectrophotometer (Gulluce et al., 2007). The following equation was used to calculate 
the scavenging percentage (antioxidant activity). 
Equation: % scavenging=100-[(Abssample-Absblank/Abscontrol)x100 
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4.3. Results and Discussion 
The antioxidant activity showed by the methanol extract of I. oblongata, was significantly 
higher (figure.4.1) in this experiment. The graph in figure 4.1.,  shows error bars with 
standard deviation. The other extracts did not show good antioxidant activity. Only 
methanol was reported because of its high antioxidant activity displayed. The 
scavenging activity was excellent when compared to the ascorbic acid which was used 
as a standard. 
 
Figure 4. 1 DPPH, ascorbic acid and Ipomoea oblongata methanol extract 





























Figure 4. 2 DPPH sScavenged free radical activity by the plant extract. 
 
The methanolic extract of I. oblongata was found to have scavenging activity on the 
DPPH assay. At 0.25 mg/ml it was 98.39% and at 0.5mg/ml it was 99.03% scavenging 
ability, as shown in figure 4.1 and figure 4.2 respectively. I. oblongata was active as the 
ascorbic acid, (see figure 4.1), showed antioxidant activity. The hydrophilic antioxidants 
contain vitamin C (ascorbic acid) and other polyphenol flavonoid groups, while the 
lipophilic antioxidants include ubiquinols, retinoids, carotenoids, apocynin, procyanidins, 
certain polyphenol flavonoid groups and tocopherols (Aggarwal and Shishodia, 2006). 
Species from the Convolvulaceae family such as I. batata L and I. carnea possess 
antioxidant properties (antimicrobial properties and wound-healing activities from their 
leaf extracts) (Khatiwora et al., 2010). This correlates with the study indicating that I. 
oblongata presented with antioxidant activity.   
Many activities such as anti-inflammatory, anti-atherosclerosis, antitumor, 
antimutagenic, anticarcinogenic, antinecrotic, hepatoprotecting drug, coronary heart 
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diseases, Alzheimer’s, neurodegenerative diseases, antibacterial and antiviral effects 
are due to antioxidant compounds and their mechanism of action (Olayinka  and Okoh, 
2010;  Ho et al., 2012). During microbial infections the hydrolysed phenolic substances 
(flavonoids) are synthesized by plants and they display antibacterial activity that forms 
complexes with extra-cellular and soluble proteins during disruption of microbial 
membranes (Mishra et al., 2013). Toxic phenolics that attack microbial pathogens are 
released by hydrolysed non-toxic glycoside found in many medicinal plants (Mishra et 
al., 2013). Literature, (Khatiwora et al., 2010; Mishra et al., 2013) states that medicinal 
plants such as Ipomoea have characteristics that can be used as therapeutic 
compounds that will aid in further research into drug development. These findings 
demonstrated that I. oblongata in the study has the potential to have antimicrobial 
properties.  
The major bioactive phenolic compounds, such as tannins and flavonoids, act as 
primary antioxidants of free radical scavengers (Singh et al., 2011), which are present in 
I. oblongata and therefore contribute to the high antioxidant activity. These significant 
findings confirm that I. oblongata has potent antioxidant activity. The Convolvulaceae 
family (Ipomoea species) is naturally rich in total phenolics and phytochemical 
compounds that enhance their antioxidant activity.  
4.4. Conclusion 
The significant antioxidant activity found in methanolic extract of I. oblongata is a rich 
source of natural antioxidants that are able to play an important role in the prevention 
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mechanisms of oxidative stress-related diseases. It is concluded that the phytochemical 
compounds found in the plant enhances the antioxidant properties of I. oblongata. 
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Anti-cancer Activity of Ipomoea oblongata 
  




Conventional anti-cancer drugs show toxicity, resistance and side effects that interfere 
with normal cell functioning and cause DNA damage (Mashele and Fuku, 2011). This 
has prompted considerable scientific and commercial interest in the innovation and 
improvement of new therapeutic anti-cancer agents from natural sources such as 
plants. Herbal medicines have played a significant role in health systems worldwide. 
Investigation has pointed out and recognized plants as reliable sources since ancient 
times, as they have the potential to provide naturally active compounds that can be 
used as therapeutic agents (Mashele and Fuku, 2011). According to Webster et al. 
(2008), plants have provided analgesics, anti-inflammatories, antineoplastic drugs, anti-
arrhythmic agents as well as medicines for asthma and hypertension. Plants are also 
natural sources that might have minimal or no side effects. A desirable anti-cancer drug 
must be selective, targeted to be cytotoxic only to cancerous cells and must not have 
the same destructive effects as conventional cytotoxic drugs (Mashele and Kolesnikova, 
2010). However, research to test more medicinal plants for anti-cancer treatment is 
proceeding relatively slowly and more studies of plants with chemical diversity such as 
I. oblongata may aid in identifying and characterizing active anti-cancer components 
(Gautam et al., 2007). 
Research worldwide is currently engaged in the development of new cancer agents in 
clinical trials based on selective activity against cancer-related molecular targets. 
Flavopiridol and combretastinA4 phosphate showed some interesting activity as new 
drug leads in cancer clinical trials (Cragg and Newman, 2005). According to Brower  
(2008), some medicinal plants have hidden sets of genes that, when found and 
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expressed, yield more compounds with therapeutic properties. The plants that contain 
effective anti-cancer agents should be prioritized in preclinical development (Brower  
2008). 
Findings on the evaluation of plants as anti-cancer agents and for human health that 
were reported in literature are, “Hydroxynitrile lyase from the leaf of Hevea brasiliensis 
has the potential to be employed as a relatively low cost resource for various anti-
microbial and anti-cancer activities due to the simplicity of latex preparation and the 
abundance of latex that can be obtained in the rubber producing regions” (Daruliza et 
al., 2011). This could be vital for the environment, as rubber is a renewable source and 
decomposable. Gynurapseudochina var. hispidia, Oroxylumindicum and Muehlenbeckia 
platycladain, Thailand, were found to be potential drug leads for anti-inflammatory 
discovery, whereas Rhinacanthus nasutus and Pouzolzia indica could possibly produce 
natural compounds as anti-cancer agents (Nisarat et al., 2010). 
These studies show more evidence that all around the world, by evaluating plants using 
diverse methods for new anti-cancer therapeutics, supplementary compounds can be 
made available for the market. Improved techniques or methods used for extraction 
should be made available to produce quality results that are not time-consuming and 
are less affected by human error. The development process should not take years to 
put drugs onto the market if there are structured relationships between plant-testing 
centers and drug developers to close gaps for natural products. 
In South Africa Koduru et al. (2007) documented the use of 17 medicinal plants to treat 
cancer in the Eastern Cape Province. They provided information including the location, 
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plant names, plant parts used and different methods of preparation as revealed by 
traditional medical practitioners, herbalists and rural dwellers. However, work still needs 
to be done to validate the traditional use as well as to isolate, purify and identify the 
active compounds in the plants. 
Steenkamp & Gouws (2006) worked on the cytotoxity of six South African medicinal 
plant extracts used in the treatment of cancer. Bidens pilosa, Centella asiatica, Cnicus 
benedictus, Dicoma capensis, Hypoxis hemerocallidea and Sutherlandia frutescens 
were used to test for cytotoxicity against three different human cancer cell lines. These 
cell lines were DU-145 prostate cancer cells, MDA-MB-231 and MCF-7 breast cancer 
cells and MCF-12A, a non-malignant breast cell line. This was done in-vitro and results 
showed that out of the six plants only D. capensis produced cytotoxic effects on the two 
breast cancer cell lines (Steenkamp & Gouws, 2006).The other plants showed no 
cytotoxicity at all. These are indications that if more testing is done on different 
medicinal plants, identification of a compound with activity can give better results than 
one particular plant. 
Schrager (2006) refers to toxicology as a division of biochemistry and medicine 
associated with the study of adverse effects of chemicals on existing organisms and 
flora. Toxicology deals with indicators, mechanisms, usages and discovery of poisoning 
of medicinal plants in recent eras. Ernest (2010) describes a Greek physician who had 
made the first attempt to classify plants according to their toxic and therapeutic effect, 
so that indicators are known for conducting toxicology assessments. A lot of research 
has been carried out on the toxicology of plants and organisms. 
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This further indicates that the medicinal plants used traditionally have the properties 
they are presumed to cover. However, the anti-cancer agents derived from plant 
extracts proving to have anti-cancer, anti-inflammatory and antioxidant activities do not 
come from one specific plant. Testing several plants will give more options for the 
discovery of new compounds for modification of anti-cancer agents. Evaluating 
medicinal plants extensively in relation to others from the same botanical family could 
provide new drug leads in the development of anti-cancer therapeutics. 
This is important, as it contributes to the database of anti-cancer treatment using 
medicinal plants in South Africa. Steenkamp & Gouws (2006) indicated that there is a 
lack of reports on plants used for cancer treatment in South Africa, hence the rationale 
for investigating I. oblongata as a locally collected plant that may contribute significantly 
to the country’s anti-cancer database. 
Anti-cancer assay 
Cell lines derived from human tumors have been reported to be extensively used as 
investigational models of cancer disease. These cell lines are different from both normal 
and cancerous tissue. The model types of human tumors and normal tissue makes it 
promising that such common cell lines will stay in future as investigational models. “The 
National Cancer Institute’s Developmental Therapeutics Program has carried out 
intensive studies of 60 cancer cell lines (the NCI60) derived from tumors from a variety 
of tissues and organs1–4” (Douglas et al., 2000). 




5.2.1 Plant material and extracts preparation 
I. oblongata was donated by one of the traditional medical practitioners of Kopanang 
Dingaka association. The plant was collected in Thaba-Nchu, identified by the traditional 
medical practitioners and a voucher specimen (KT001/2013) was kept at the Central 
University of Technology Free State and authenticated by scientists at the National 
Botanical Gardens in Bloemfontein. Plant material (roots) were dried in the oven at 40⁰C 
for 5 days, crushed into a fine powder and stored in a plastic jar. The plant was kept in a 
cool dry area in the laboratory (Mashele and Kolesnikova, 2010). 
For the preparation of aqueous (H2O), methanol and dichloromethane extracts, 
Ipomoea oblongata roots were weighed to obtain 10 g. Plant roots were dried in the 
oven at 40⁰C for 5 days, crushed into a fine powder material.  The powdered material 
was soaked for 72 hours in 150 ml of the different solvents and stirred using a rotary 
shaker. The water, methanol and dichloromethane extracts were filtered through 
(Whatman No. 1) filter paper. The solvents were dried at 40⁰C using a rotary evaporator 
to remove the solvents and make the final volumes of the original plant material. 
Three of the 60 human cell lines, namely MCF7 (breast), HCT116 (colon cancer) and 
PC3 (prostate cancer) were used in this study by sulforhodamine B (SRB) assay. SRB 
assay is a method developed by Skehan and collaborators to measure drug-induced 
cytotoxicity and cell proliferation. Its principle is based on the ability of the protein dye 
sulforhodamine B (Acid Red 52) to bind electrostatically in a pH-dependent manner to 
protein-basic amino acid residues of trichloroacetic acid-fixed cells. The protein dye also 
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binds to the fixed cellular protein under mild acidic and basic conditions. Therefore it 
can be extracted from cells and solubilized for measurement. The SRB assay was 
performed at the Council for Scientific and Industrial Research (CSIR) in accordance 
with the protocol of the Drug Evaluation Branch, NCI, and has been adopted for the 
specific screening of cancer. Maintenance of cell lines as monolayer cell cultures was 
routinely done according to Table 5.1: 
 
Table 5. 1 Material used for the cancer assay 
Temperature Gas Contents 
37oC 5% CO2 5% fetal bovine serum 
37oC 95% air 2 mM L-glutamine 
 
100% relative humidity in 
RPMI 50 µg/ml gentamicin 
Blank = complete medium without cells, Control = cells without drug addition; Standard 
= Etoposide 
The 96-well micro-titer plates were inoculated at a plating density of 7-10 000 cells/well 
(figure 5.1.). Inoculation time was 24 hours refer to figure 5.4. One plate was fixed with 
trichloroacetic acid (TCA), incubation time to present measurements of cell population 
for each cell line at the T0 (time of drug addition). Other plates with cells were treated 
with the experimental drug refer to figure 5.3., (I. oblongata extract). The extract was 
dissolved in dimethyl sulfoxide (DMSO) and diluted in medium to produce 
concentrations of 6.25-100 µg/ml / 0.01-100 µM and the vortex process is shown in 
figure 5.2.. The second incubation time was 48 hours after addition of the test 
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compound (extracts) refer to figure 5.5.B. Viable cells that were fixed at the bottom of 
each well were washed with 50% TCA (figure 5.5.C), dried and the SRB dye was added 
as shown in figure 5.5 A. The unbound dye was removed. Protein-bound dye was 
extracted with 10 mM Trisbase to determine optical density as shown in figure 5.5.D. 
The optical density was measured at 540 nm using a multiwall spectrophotometer. 
Absorbance readings were used to calculate net percentage of cell growth. TGI means 
total growth inhibition. Ti means optical density of the test well after 48 hours of 
exposure. T(0) means optical density at time zero. C means control optical density.  
[(Ti-T0)/(C-T0)] x 100 for concentrations at which Ti≥T0 
[(Ti-T0)/T0] x 100 for concentrations at which Ti<T0. 
The results of five dose screening were reported as TGI .The TGI is the concentration of 
the test drug where 100 x (T-T0)/(C-T0) = 0. The TGI signifies a cytostatic effect where 
cells are neither splitting nor growing. The assay conditions were as follows: one 
sample was screened with the test sample concentration of about 100- 6.25 µg/ml (5 x 
2-fold serial dilutions). The standard (Etoposide) concentration was 100 - 6.25 µg/ml (5 
x 2-fold serial dilutions) and the absorbance were read at 540 nm. 
 




Figure 5. 1 Cell lines in the 96 microtiter plate placed on orbital shaker at 150rpm 
 
Figure 5. 2 Vortex Process of I. oblongata extract 




Figure 5. 3Inoculation of cell lines in different medium 
 
Figure 5. 4 Inoculation of cell lines in a microtiter plate using multi- pipette 










Figure 5. 5 A:  Addition of Sulforhodamine B (SRB dye)  
B: Unbound cell lines dyed and incubated at 48 hours  
C: Rinsing of SBR dye from cell lines     D: Washed cell lines 
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5.3. Results and Discussion 
For each tested compound, four response parameters, GI50 (50% growth inhibition and 
signifying the growth inhibitory power of the test agent), TGI (which is the drug 
concentration resulting in TGI and signifies the cytostatic effect of the test agent), LC50 
(50% lethal concentration, which signifies the cytotoxic effect of the test agent), LC100 
(100% lethal concentration, signifying the cytotoxic effect of the test agent), were 
calculated for each cell line (Mashele and Fuku, 2011) with the Z’ Factor equal to 0.8-0 
for absorbance at 540 nm. According to the criterion of the CSIR, Pretoria, the extracts 
are considered inactive if the parameter TGI for two cell lines is higher than 50 µg/ml.  
The methanolic extract of I. oblongata was considered inactive for all three cell lines 
(MCF7, HCT116 & PC3) in all four parameters used in determining the cell viabilities 
and cytotoxicity to the cancer lines by using the lethal concentration (LC) parameter at 
50% and 100%. The positive control (Etoposide) was also inactive for all cell lines 
within the four parameters, especially TGI, LC50 and LC100, which are significantly 
higher (>100). The growth inhibition at 50% (GI50) for the cell lines MCF7, HCT116 and 
PC3 for the drug Etoposide was less inactive compared to that of the crude extract, 
which was highly inactive. The TGI value was significantly higher than the required TGI 
to be regarded as potent (refer to figure 5.1 and figure 5.2 as indicated above). 
Table 5. 2. CSIR criteria for anticancer activity  
TGI Status TGI Status 
> 50 µg/ml Inactive < 15 > 6.25 µg/ml Moderate activity 
< 50 >15 µg/ml Weak activity < 6.25 µg/ml Potent activity 
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Table 5.3. Anti-cancer activity of Ipomoea oblongata 







Etoposide MCF7 <6.25 >100 >100 >100 Inactive 
HCT116 19.96 >100 >100 >100 Inactive 
PC3 34.64 >100 >100 >100 Inactive 
Ipomoea 
oblongata 
MCF7 92 >100 >100 >100 Inactive 
HCT116 >100 >100 >100 >100 Inactive 
PC3 >100 >100 >100 >100 Inactive 
Key notes; (GI50 = 50% growth inhibition), (TGI = total growth inhibition; drug concentration resulting in total 
growth inhibition), (LC50 = 50% lethal concentration), (LC100 = 100% lethal concentration) 
Figure 5. 6 Anti-cancer activity of Etoposide and the methanolic extract of Ipomoea oblongata 




South Africa has contributed significantly to research for potential therapeutic drugs 
using medicinal plants, which were used and are still used by traditional medical 
practitioners to treat a list of diseases including cancer. Traditional Medical Practitioners 
used infusions without any scientific research into their efficacy and safety but still 
showed remarkable results after use for a long time. For example, in KwaZulu-Natal, 
Cyphostemma natalitium (Vitaceae), a Zulu traditional medicinal plant, was evaluated 
for anti-inflammatory and anti-microbial activity and showed potential in treating cancer 
patients. Other potential cancer chemopreventive agents such as resveratrol (with anti-
inflammatory and anti-mutagenic properties) from Vitis vinifera have been derived from 
Vitaceae (Lin et al., 1999).   
The plant I. oblongata was inactive for anticancer activity, but its traditional uses by 
traditional medical practitioners were reported to have anti-inflammatory activities. 
Anticancer activity of Ipomoea oblongata and the etoposide are represented in table 
5.3, showing TGI, LC50 and LC100 of more 100% inhibition of the breast, colon and 
prostate (MCF7, HCT116 and PC3). The GI50 of the etoposide in all 3 cancer cell lines 
showed cell inhibition of less than 100% as wells as the breast cancer cell line of 
Ipomoea oblongata. Cell viability of the test extract and the standard are presented in 
figure 5.7., in all the 3 cancer cell lines. The results were anticipated to have some 
anticancer activity since I. oblongata had claims of anti-inflammatory properties and its 
methanolic extract of showed antioxidant activities in chapter 4. As a result the anti-
cancer screening will be repeated using different cell lines and control to eliminate any 
errors that might have occurred during the experiment. 
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 The breast cancer cell line (MCF7) growth was inhibited (inactive) by the extracts of 
Hypoxis hemerocallidea (Steenkamp & Gouws, 2006).  There is still a need to develop 
drug agents from medicinal plants. In a study conducted on the anti-cancer activity and 
cytotoxicity of Bauhinia variegata extracts, the ethyl acetate extracts showed cytotoxicity 
to leukemia (THP-1) and breast cancer (MCF-7) cell lines, whereas the aqueous 
fraction was the most potent extract with anti-cancer activity and considerable cytotoxic 
effect on all cell lines used (Mishra et al., 2013). The cellular composition of the cell 
lines used in this study could have contributed to the inactivity of the I. oblongata and 
the Etoposide. 
Extensive research was done using plant extracts and cell lines in an attempt to identify 
the chemotherapeutic and chemoprevention agents that can offer potent anti-cancer 
therapy with fewer or no toxic effects compared to the current chemotherapy (Mishra et 
al., 2013). The anti-cancer effect produced by plant extracts stems from bioactive 
compounds such flavonoids, saponins and anthraquinones that function like 
antioxidants. I. oblongata has the potential for anti-cancer activities owing to the 
presence of flavonoids and high levels of antioxidants, as shown in chapter 4, figure. 
4.1. 
5.4. Conclusion 
The extracts of Ipomoea oblongata and the standard Etoposide were inactive for the cell 
lines MCF7, HCT116 and PC3, but further anti-cancer screening should be done using 
different standards and cell lines. 
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Antidiabetic and Cytotoxicity Activities 
 
  




Diabetes mellitus is an endocrine disorder characterized by abnormal protein, 
carbohydrates and fat metabolism. This can result from lack of normal insulin production 
and release by the islet cells of the pancreas, causing degenerative diseases (Marles 
and Farnsworth, 1995; Patel et al., 2012a). Complications associated with diabetes 
mellitus are cardiovascular ailments, stroke, blindness, neuropathy, gangrene, 
nephropathy and kidney failure (Marles and Farnsworth, 1995). According to WHO 
there are three types of diabetes. Type 1-insulin-dependent diabetes mellitus  is 
characterized by lack of or insufficient insulin production. It is treated by injecting the 
patient with insulin to prevent catabolic flow resulting in diabetes ketoacidosis, coma 
and even death and β-cells causing further insufficient insulin secretions in the pancreas 
(Marles and Farnsworth, 1995). 
Type 2-non-insulin-dependent diabetes mellitus (NIDDM) is regarded as a decrease in 
β-cells compared to α-cells. There is enough insulin to oppose the ketogenic processes 
of glucagon but it is unable to prevent hyperglycaemia. NIDDM mostly occurs in elderly 
(above 65 years) and obese people and it can be corrected with diet and drugs from 
natural sources with minimal side effects (Marles and Farnsworth, 1995). It is also a 
progressive ailment identified by higher levels of glucose caused by the inability of the 
pancreas to secrete insulin, hyperglucagoneamia and decreased insulin sensitivity 
(Marles and Farnsworth, 1995; Vilsboll et al., 2009).  Type 3 is malnutrition–related 
diabetes mellitus (MRDM), which occurs in young people with a history of malnutrition 
such as kwashiorkor and other diseases from tropical areas in developing countries 
(Marles and Farnsworth, 1995). 
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Type 2 is the form of diabetes mellitus studied most intensively because of its micro- 
and macrovascular complications resulting in damage to organs such as the heart, 
eyes, blood vessels, nerves and kidneys (Vilsboll et al., 2009).  It has become the most 
important research aspect in seeking drug derivatives from medicinal plants to assist in 
regulation of glucose homeostasis (Vilsboll, et al., 2009).  Any plant that will provide this 
mechanism will prevent adverse events such as death, weight gain, hypoglycaemia and 
the risks associated with macro- and micro-vascular complications (Vilsboll, et al., 
2009). 
Conventional treatment methods for Type 2 diabetes do not address the serious 
progression fairly. The low levels of β-cells mass are washed out. There is a need to 
supplement treatment with insulin injections or equivalents that do not result in weight 
gain and hypoglycaemia (Vilsboll et al., 2009).  Sulphonylreas (SU) has been shown to 
intensify apoptosis in normal human beta cells. There are complications with the use of 
SU such as increase in body weight and hypoglycaemia (Vilsboll, et al., 2009).  Vilsboll 
et al. (2009) reported findings about anti-diabetic drugs from traditional plants such as 
thiazolidinedione (TZDs), repaglinides and metformin with alpha glycosidase inhibitors. 
These drugs have adverse effects such as weight gain, hypoglycaemia and 
gastrointestinal effects (Vilsboll, et al., 2009).    
 Researchers aim to find and isolate other compounds from plants that lower the blood 
glucose with as few side effects as possible, preferably none. Many more plants such 
as I. oblongata in Southern Africa can be explored as new leads in diabetes mellitus 
treatment and in view of its antioxidant activity discussed in chapter 5, it could possibly 
be a potent anti-diabetic agent. Valuable drug leads for diabetes can be derived from 
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herbal remedies to help in the pathology of diabetes mellitus. The cost and availability of 
medication will be reduced for many developing countries, unlike the current treatment 
(Marles and Farnsworth, 1995). A review was conducted on 1200 plant species and 
reported ethnobotanical uses in treating diabetes (Marles et al., 1995). The data 
reported on the mechanisms of action, hypoglycaemic activity bioassays of 
hypoglycaemic agents and cytotoxicity problems associated with active constituents of 
medicinal plants used in diabetes treatment (Marles and Farnsworth 1995). A study was 
conducted on 65 medicinal plant species with hypoglycaemic properties, which included 
part of the plants used, mode of reduction in blood glucose and active phytochemical 
contents having insulin properties (Patel et al., 2012b). 
6.2. Materials and Methods 
6.2.1. In vitro glucose uptake model in C2C12 muscle cells 
The cells (C2C12) were cultured in DMEM medium containing 10% fetal bovine serum 
at 37ºC in humidified air with 5% CO2.  Muscle C2C12 cells were seeded at a density of 
4 000 cells per well into a 96-well culture plate and cultured for three days.  C2C12 cells 
were differentiated for another two days in DMEM supplemented with 2%.  After 
differentiation, cells were acutely exposed for three hours to the methanol, water. The 
extracts were diluted at concentrations of 50 µg/mL, metformin (1 µM), insulin (1 µM). 
The solvent control (DMSO/water) was added to the modified DMEM media 
supplemented with 8 mM of glucose. The glucose concentrations remaining in the wells 
were determined using a commercial fluorimetric kit. After three hours of exposure to 
the media containing glucose, glucose uptake was calculated by subtracting the glucose 
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concentration remaining in the test wells from the glucose concentration of media 
measured in wells not containing cells.  The cell passage number was <10. All samples 
were tested in triplicate (Medical research council SA). 
6.2.2. In vitro glucose uptake model Chang liver cells 
The Chang cells were cultured in EMEM growth medium containing 10% fetal bovine 
serum at 37ºC in humidified air with 5% CO2.  Cells were planted at 6 000 cells per well 
into a 96-well culture plate and cultured for up to five days. Thereafter cells were acutely 
exposed for three hours to methanol, water and decoction extracts at different  
concentrations of 50 µg/mL, metformin (1 µM), insulin (1 µM). The solvent control 
(DMSO/water) was added to the modified EMEM media supplemented with 8 mM of 
glucose. The glucose uptake was determined after three hours using a glucose oxidase 
fluorimetric assay.   The glucose uptake from the media was calculated as described for 
C2C12 muscle cells. The cell passage number was <10, (Medical research council SA). 
6.2.3. Glucose detection method 
The measurement of glucose concentration in the media was determined using a 
glucose oxidase fluorimetric assay. Fluorescence was measured at Ex/Em = 535/587 
nm using a BioTek FX800 fluorimeter. According to the protocol of Biovision, glucose 
oxidase plays an important role in oxidation of beta-D-glucose into hydrogen peroxide 
and D-glucacon-1-5-lactone and is finally hydrolyzed into gluconic acid. Glucose uptake 
fluorimetric assay is a non-radioactive, sensitive reaction used to determine glucose 
uptake at low concentrations and can be applied in various cell lines, as shown in figure 
6.3, b, c and d with the protocol standards (Biovision, USA). Glucose uptake is an 
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important biological process for studying cell signaling and glucose metabolism. The 
glucose transporters metabolize glucose into 2-Deoxyglucose-6-phosphate (2-DG6P) 
and during this stage excess glucose accumulates in the cells and cannot be 
metabolized further (Biovision, USA) as shown in figure 6.1.  The accumulated 2-DG6P 
is oxidized by enzyme reaction and later coupled with Pico Probe (Biovision, USA), 
which produces fluorescence in the presence of NADPH. 
6.2.4. Cytotoxicity assay 
The cells’ viability in the study was 100% that was represented in wells and assessed 
using the Mossman tetrazole test (MTT) assay.  The cell passage number was below 
10. The samples were tested in triplicate in a single experiment. MTT (3-(4,5-
dimethythiazol-2-yl)-2,5-diphenyltetrazolium-bromide is a colorimetric assay that 
measures the reduction of the yellow MTT color by mitochondrial dehydrogenase to 
dark purple formazan crystals in living cells (Mosmann, 1983; Ulukaya et al., 2008). The 
solubilized formazan precipitate was measured by spectrophotometer at 570 nm. The 
method used in this study was described by Mosmann (1983), and carried out in 
collaboration with the Medical Research Council. 
6.2.5. Data analysis 
The data generated was analyzed using Microsoft Excel by calculating the mean and 
standard deviation and by graphical representation. Results are expressed as mean 
and standard error mean (SEM) of a single experiment with triplicates per sample. 
 




Figure 6. 1 Glucose Uptake Fluorimetric Assay kit (Biovision, USA) 
6.3. Results and Discussion 
The percentage glucose uptake for antidiabetic activity of Ipomoea oblongata methanol 
extract was 66.3% lower than the vehicle control (20% DMSO)  100% and metformin 
with 157% in the muscle cell line. The insulin was 193% glucose uptake as compared to 
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the water extract that was 182% higher than vehicle control and metformin when 
compared to insulin (see table 6.1). Therefore the water extract showed antidiabetic 
activity in muscle cell lines similar to that of insulin. In table 6.2., the antidiabetic 
percentage glucose uptake in the chang liver cancer cell lines displayed activity in both 
water (88.40%) and methanol (99.81%) extracts which are comparable to the vehicle 
control (100.9%). Metformin (116.79%) and insulin (114.41) illustrated higher levels of 
antidiabetic properties in the glucose uptake of chang cells. Cytotoxicity is represented 
in figure 6.1., with methanol and water extracts having cell viability below 100%. The 
plant is regarded as a low hazard plant.   










Ave 100 157.02 192.23 182.35 66.3 
SD 1.88 34.13 54.59 47.05 3.31 
SEM 0.94 19.7 19.3 27.16 1.65 
 










Ave 100.9 116.79 114.41 88.40 99.81 
SD 12.60 1.28 3.02 24.09 4.16 
SEM 4.20 0.57 1.35 9.84 1.70 
 




Figure 6. 2 Cytotoxicity using MTT assay in C2C12 cell lines and Chang cell lines 
 
The treatment of diabetes is mainly focused on controlling plasma glucose levels and 
achieving insulin derivative effects (Lopez-Viseras et al., 2013). Glucose uptake by the 
aqueous extract in the C2C12 muscle cells was increased by over 182.35%, which is 
comparable to that of insulin (positive control) and metformin (reference drug control), 
suggesting good anti-diabetic activity (Table 6.1). The leaves of Ipomoea aquatica are 
reported to have anti-diabetic activity (Patel et al., 2012c). 
 However, in the Chang liver cells the water extract reduced the glucose uptake by 
88.4% (refer to Table 6.2). Glucose uptake and insulin release are suggestive of 
hypoglycemic effects. Hypoglycemic effects are due to the action on hepatic 
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efficiency by peripheral tissue, impairment occurs as a result of decreased insulin 
secretion and defective cellular insulin action (Patel et al., 2012a). Insulin as a protein 
structure requires compounds such as vanadium, which has shown hypoglycaemic 
action used in diabetes therapy (Lopez-Viseras et al., 2013). The enzymatic and non-
enzymatic antioxidative mechanism can reduce the generation of reactive oxygen 
species liable for degenerative diseases (Vilsboll et al., 2009).  Anti-diabetic plants with 
different activities, such as Cuscuta reflexa (Convolvulaceae), containing high phenolic 
constituents, were described by Patel et al. (2012c).  Ipomoea species have proven to 
be anti-diabetic plants from which compounds can be isolated for use as new diabetic 
drugs agents. 
The methanol extract of I. oblongata reduced glucose activity and it is not regarded as a 
good anti-diabetic extract.  Methanolic extract of I. oblongata reduced MTT activity by 
>15%, thus was suggestive of cytotoxicity, as shown in figure 6.5. The toxicity as 
indicated by the SBR assay on the Vero cells showed that the methanol extract had low 
hazard activity. Therefore it means that the cytotoxicity is low and can be tested further 
with ATP assay to confirm cytotoxicity levels. The mechanisms of action found in the 
tuber of Ipomoea batata was in the reduction of insulin resistance and blood glucose 
level (Patel et al., 2012c).  This is an indication that plants from the Convolvulaceae 
family are strong anti-diabetic agents because of their ability to imitate insulin activities. 
The water extract had no adverse effect on C2C12 muscle cell viability and Chang cell 
viability as estimated by MTT assay at the concentration tested (50 µg/mL). It is evident 
that it is possible for medicinal plants to have no cytotoxicity when tested. Literature 
states that toxicological effects of many crude extracts have been overlooked because 
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of the belief that medicinal plants have better compatibility with the human body owing 
to fewer side effects. Cytotoxicity testing plays an important role as a standard 
procedure of the biological evaluation of pharmacology (Ashafa et al., 2013). An 
important discovery has been the mononuclear zinc compound’s anti-diabetic activity 
(Lopez-Viseras et al., 2013). Deficiency in zinc occurs in diabetic patients and this 
activity thus reverses the diabetes-induced zinc status (Lopez-Viseras et al., 2013).  
Zinc affects the structural position of proteins, including insulin-enhancing activities 
(Lopez-Viseras et al., 2013). There is  a need to find structural protein from medicinal 
plants that will not affected by the zinc. 
Bioactive compounds such as polyphenols, alkaloids, flavonoids, glycosides, 
carotenoids, terpenoids, coumarins and other phytochemical constituents greatly 
contribute to the anti-diabetic activity of medicinal plants, causing reduction in blood 
glucose levels (Patel et al., 2012b). The presence of the phytochemical compounds 
present in I. oblongata, as indicated in Chapter 4 (Table 4.1), contributed to the ability of 
this plant to have anti-diabetic activity. The anti-hyperglycemic effect of the plants is to 
restore the function of pancreatic tissues.  There should be an increase in insulin output 
and/or inhibition of intestinal absorption of glucose. It should also facilitate the 
metabolites available in insulin-dependent processes (Patel et al., 2012a). 
6.4. Conclusion 
Aqueous extract of the I. oblongata is a good anti-diabetic source, whereas the 
methanol extract is not a good source. Cytotoxicity is regarded to be a low hazard in 
© Central University of Technology, Free State
84 
 
Ipomoea oblongata for human cell lines. The active compounds for anti-diabetic activity 
will be isolated in later studies. 
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